Scientist Stories: Saar Gill, CAR macrophage therapies at the limits

Saar Gill is an associate professor of medicine in the division of hematology-oncology at the University of Pennsylvania. Dr Gill trained in clinical hematology in his native Australia, followed by a post-doctoral fellowship at Stanford University. Since 2011 he has been working on developing genetically engineered immune cells for the treatment of cancer. Dr Gill is a physician-scientist who places a strong emphasis on translational research, and concepts developed in his laboratory have already led to several clinical trials for the treatment of hematologic malignancies. Dr. Gill co-founded Carisma Therapeutics with his first graduate student, Michael Klichinsky, and recently co-founded Interius Biotherapeutics. He is a member of the American Society of Hematology Scientific Sub-Committee on Myeloid Neoplasia, elected to the American Society of Clinical Investigation, a past chair of the Cancer and Gene Therapy committee of the American Society of Gene & Cell Therapy, and a co-chair of the American Society of Transplantation and Cell Therapy’s Women, Under-represented Minorities and LGBTQ Special Interest Group.
www.med.upenn....
#biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews
Axial Newsletter: axial.substack...
Build with Axial: build.axialvc....